November 2023 – Kinstellar, Gen Temizer | Özer have successfully advised British Petroleum (bp) on the sale of its downstream business in Türkiye to Petrol Ofisi, Vitol’s Turkish subsidiary. The transaction is the most significant oil & gas...
November 2023 – Kinstellar Gen & Temizer | Özer have successfully advised Property Finder and Zingat on the sale of 100% of Zingat to hepsiemlak, and Property Finder’s subsequent share subscription into hepsiemlak.
September 2023 – Turkey’s Competition Board (the "Board") rendered two significant decisions last year concerning online sales restrictions that provide a view forward for many undertakings. In its decisions, the Board scrutinised the commitment packages...
July 2023 – Kinstellar, together with a lead counsel Watson Farley & Williams, have successfully advised Yanolja Cloud, a leading global provider of AI-based SaaS solutions for the hospitality and leisure industries, on the multi-jurisdictional...
June 2023 – Kinstellar, Gen Temizer Özer have successfully advised the Gora Family on the sale of 100% of their shares in Murat Ticaret, a Turkish complex wire harness manufacturer, to Volex plc, a UK-listed specialist integrated manufacturer of critical...
April 2023 – The recent resolution of the European Parliament on video games calls on the European Commission to take the necessary steps to bring about a European approach to loot boxes which could lead to more restrictive regulation.
April 2023 – The healthcare industry in Central and Eastern Europe and Turkey is undergoing a digital transformation, with telemedicine at the forefront. Governments and healthcare providers are adopting digital solutions to improve medical services...
February 2023 – The European Commission and European Intellectual Property Office (“EUIPO”) have launched a small and medium sized business fund (SME Fund) to provide reimbursement for trademark and design application fees and pre diagnostic services.
January 2023 – The rapid development of technologies and solutions in the healthcare sector is contributing to the proliferation of decentralised clinical trials (“DCTs”). The aim of DCTs is for clinical trials to be conducted more effectively...
January 2023 – Kinstellar is delighted to announce the appointments of new service line heads.